Google+ Facebook Twitter Twitter

Decreased testing could lead to STI surge

Screening and testing for sexually transmitted infections (STIs) in the US decreased by 63% for men and 59% for women during the early months of the pandemic.

The researchers behind the figures said this may be the result of restrictions placed on direct patient care and shifts to telehealth and could lead to a possible future surge in STI cases.

Due to social distancing measures and supply constraints, screening guidelines issued by the CDC during the pandemic recommended halting STI tests except  for patients exhibiting symptoms.

However, researchers say that these recommendations were detrimental, because risk-based screenings were paused, in favour of symptomatic testing, even though the majority of people (80%) with chlamydia or gonorrhoea are asymptomatic.

The research team reviewed more than 18 million STI test results from patients aged 14–49 from January 2019 to June 2020 and found that the pandemic had an adverse impact on sexual health screening.

Among male patients, the researchers noted increases in test positivity rates for both chlamydia (18%) and gonorrhoea (41%) during the pandemic.

For female patients during the pandemic, there was an increase in the test positivity rates for chlamydia (10%) and gonorrhoea (43%) infections.

Image credit | iStock


Related Articles

Diffuse optics for diagnosticsDiffuse optics for diagnostics

Among the optics-based tools used in diagnostics, diffuse optics (DO) is rapidly emerging as one of the most attractive technologies.

Clinical andrology: overcoming barriers, improving outcomes

Clinical Scientist and Andrology Service Lead Stuart Long on the impact that taking on a patient-facing role can have.

Acute lymphoblastic leukaemia

Lecturer in Biomedical Science at the University of Salford Tahmina Hussain looks at leukaemia and presents a case study.

Four days in March: An advisory view of congress

With Congress fast approaching, Brian Nation, IBMS Editorial Specialist Advisor, looks at a few programme highlights of the forthcoming biennial event at the International Convention Centre in Birmingham next March.